• If you are wondering whether Brown & Brown is starting to look interesting at its current share price, it helps to step back and ask what you are really paying for in this insurance broker's future cash flows.
• The stock closed at US$55.35, with returns declining about 4% over the last week, 15% over the last month, 28.7% year to date and 49.6% over the past year. This will naturally raise questions about whether recent price moves reflect changing expectations or create a potential mispricing.
• These share price moves have put more attention on how the insurance sector is being priced and where Brown & Brown fits in that picture. For investors, this means the current valuation conversation is less about a short term headline and more about how the market is recalibrating its view of risk and reward for the stock.
• On Simply Wall St's 6 point valuation checklist, Brown & Brown scores a 4 out of 6. This suggests some parts of the market are treating it as undervalued on several measures. The sections that follow will walk through those methods before finishing with a broader way to think about what that score really means for you.

Approach 1: Brown & Brown Excess Returns Analysis

The Excess Returns model asks a simple question: is Brown & Brown generating earnings that are meaningfully higher than the return investors require on its equity, and can that gap reasonably persist into the future?

For Brown & Brown, the model uses a Book Value of $37.58 per share and a Stable EPS estimate of $6.34 per share, based on weighted future Return on Equity estimates from 4 analysts. The implied Average Return on Equity is 14.77%, while the Cost of Equity is $3.05 per share, which yields an Excess Return of $3.29 per share. In parallel, a Stable Book Value of $42.94 per share is used, sourced from weighted future Book Value estimates from 2 analysts.

By capitalising these projected excess returns over time, the model arrives at an intrinsic value of about $135.19 per share. Compared with the recent share price of $55.35, the Excess Returns framework implies the stock is about 59.1% undervalued on these assumptions.

Result: UNDERVALUED

Our Excess Returns analysis suggests Brown & Brown is undervalued by 59.1%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.

Approach 2: Brown & Brown Price vs Earnings

For a profitable company like Brown & Brown, the P/E ratio is a useful shortcut because it tells you how many dollars you are paying for each dollar of current earnings. It is a simple way to line up the stock against alternatives that also generate earnings today.

What counts as a "normal" P/E depends a lot on what investors expect from a company’s future and how risky they think those earnings are. Higher expected growth or lower perceived risk can justify a higher multiple, while lower growth or higher risk usually point to a lower one.

Brown & Brown currently trades on a P/E of 16.5x. That is above the Insurance industry average of 11.18x, but below the peer group average of 24.99x. Simply Wall St’s Fair Ratio for Brown & Brown is 12.68x, which is a proprietary estimate of what the P/E might be given the company’s earnings profile, industry, profit margins, market cap and risk factors. Because it is tailored to the company rather than just a broad group, it can give a more company specific reference point than simple industry or peer comparisons. On this basis, Brown & Brown’s current P/E of 16.5x sits above the Fair Ratio of 12.68x, which points to the stock being priced on the higher side relative to those fundamentals.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Brown & Brown Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives bring this to life by letting you set a clear story for Brown & Brown, link that story to your own revenue, earnings and margin assumptions, translate those into a Fair Value, and then compare that Fair Value with the current price. All of this happens within the Simply Wall St Community page, where Narratives are used by millions of investors and are automatically refreshed when new news or earnings arrive. One investor might build a Narrative that lines up with the higher analyst fair value of US$90.00 based on confidence in acquisitions, cost control and ongoing buybacks. Another might lean toward the lower US$65.00 view if they put more weight on risks like regulatory change or pressure on profit margins. The gap between Narratives shows why the story you believe and the numbers you plug in should guide how you think about your own decisions.

Do you think there's more to the story for Brown & Brown? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.